PP
Pawan Pandey
About Pawan Pandey
Data last updated:
Pawan Pandey is a Director at Lucrose Pharma Private Limited (since 2025) and Whole-Time Director at Diggal Pharma Private Limited (since 2025). The companies operate in Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹27.44 Cr; the largest is Lucrose Pharma Private Limited at ₹22.61 Cr (FY 2025). Earlier, Pawan Pandey was a Director at Octavia Pharmaceuticals Private Limited (from 2013).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Lucrose Pharma Private Limited U74999UP2016PTC084888 | Director | 10 May 2025 | 2016 | ₹22.61 Cr (FY 2025) | Active |
 Diggal Pharma Private Limited U51909UP2021PTC152064 | Whole-Time Director | 10 May 2025 | 2021 | ₹4.83 Cr (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Octavia Pharmaceuticals Private Limited U74999MH2013PTC242659 | Director | 30 Apr 2013 | 2013 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Pawan Pandey
| Name | DIN | Company | Designation |
|---|---|---|---|
| Amit Verma | 08474655 | Lucrose Pharma Private Limited , Diggal Pharma Private Limited | Director |
| Anita Singh | 03369261 | Lucrose Pharma Private Limited , Diggal Pharma Private Limited | Director |
| Dinesh Kumar | 07519621 | Lucrose Pharma Private Limited , Diggal Pharma Private Limited | Director |
| Gajendra Singh | 02079524 | Lucrose Pharma Private Limited , Diggal Pharma Private Limited | Director |
| Rashmi | 09316743 | Diggal Pharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Pawan Pandey
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Pawan Pandey
Pawan Pandey currently holds 2 directorships: Lucrose Pharma Private Limited (Director, since 10 May 2025, revenue ₹22.61 Cr (FY 2025)); Diggal Pharma Private Limited (Whole-Time Director, since 10 May 2025, revenue ₹4.83 Cr (FY 2025)).
Pawan Pandey was first appointed on 30 Apr 2013 as Director at Octavia Pharmaceuticals Private Limited. The most recent appointment on record is 10 May 2025 at Diggal Pharma Private Limited.
The 2 current companies of Pawan Pandey that report revenue have a combined latest revenue of ₹27.44 Cr: Lucrose Pharma Private Limited ₹22.61 Cr (FY 2025); Diggal Pharma Private Limited ₹4.83 Cr (FY 2025).
Pawan Pandey held 1 earlier board appointment: Octavia Pharmaceuticals Private Limited (Director, from 30 Apr 2013).
The current boards of Pawan Pandey's companies include Amit Verma (Lucrose Pharma Private Limited), Anita Singh (Lucrose Pharma Private Limited), Dinesh Kumar (Lucrose Pharma Private Limited), Gajendra Singh (Lucrose Pharma Private Limited), Rashmi (Diggal Pharma Private Limited).